Product Description
Lippod 50mg Injection by Celon Laboratories contains Doxorubicin Hydrochloride in liposomal form (50 mg per 25 ml vial, 2 mg/ml), a prescription anti-cancer (cytotoxic) medicine. It is prescribed by an oncologist and given only by trained healthcare professionals as an intravenous infusion.
Key Benefits
Prescribed as part of cancer treatment under specialist supervision
Liposomal formulation: the doxorubicin is enclosed in a fatty capsule (liposome) that lets it stay in the bloodstream for longer
Works by damaging the DNA of cancer cells, stopping their growth and multiplication
Higher-strength 25 ml single vial, for doses based on body surface area
Made in India by Celon Laboratories
Key Ingredient & Its Use
Doxorubicin Hydrochloride (Liposomal) 50 mg per 25 ml vial: an anthracycline anti-cancer medicine. Liposomal doxorubicin is prescribed for conditions such as ovarian cancer, multiple myeloma (with bortezomib) and AIDS-related Kaposi's sarcoma, and in some regimens for breast cancer. The exact indication and dose are decided by the oncologist.
How to Use
To be given only by a doctor or trained healthcare professional, as an intravenous infusion
Dose and schedule depend on the condition, body surface area and the oncologist's protocol
Do not self-administer
Do not substitute for conventional doxorubicin. The two are not interchangeable, and the doctor decides which one is used
Technical Specifications
Brand: Lippod
Product Name: Lippod 50mg Injection
Product Type: Prescription anti-cancer injection (Doxorubicin Hydrochloride, Liposomal)
Strength: 50 mg/25 ml (2 mg/ml)
Net Quantity: 1 vial (25 ml)
Pack Type: Single vial in a box
Suitable For: Adults, as prescribed by a specialist
Storage: Refrigerate at 2–8°C. Protect from light. Do not freeze.
Country of Origin: India
Manufacturer: Celon Laboratories Ltd
